Search Page

1

Cite

Share

Advances in Antibody Design.

Tiller KE, Tessier PM. Tiller KE, et al. Among authors: tessier pm. Annu Rev Biomed Eng. 2015;17:191-216. doi: 10.1146/annurev-bioeng-071114-040733. Epub 2015 Aug 14. Annu Rev Biomed Eng. 2015. PMID: 26274600 Free PMC article. Review.

Cite

Share

2

Cite

Share

Toward Drug-Like Multispecific Antibodies by Design.

Sawant MS, Streu CN, Wu L, Tessier PM. Sawant MS, et al. Among authors: tessier pm. Int J Mol Sci. 2020 Oct 12;21(20):7496. doi: 10.3390/ijms21207496. Int J Mol Sci. 2020. PMID: 33053650 Free PMC article. Review.

Cite

Share

3

Cite

Share

High-throughput screening for developability during early-stage antibody discovery using self-interaction nanoparticle spectroscopy.

Liu Y, Caffry I, Wu J, Geng SB, Jain T, Sun T, Reid F, Cao Y, Estep P, Yu Y, Vásquez M, Tessier PM, Xu Y. Liu Y, et al. Among authors: tessier pm. MAbs. 2014 Mar-Apr;6(2):483-92. doi: 10.4161/mabs.27431. Epub 2013 Dec 6. MAbs. 2014. PMID: 24492294 Free PMC article.

Cite

Share

4

Cite

Share

Engineering aggregation-resistant antibodies.

Perchiacca JM, Tessier PM. Perchiacca JM, et al. Among authors: tessier pm. Annu Rev Chem Biomol Eng. 2012;3:263-86. doi: 10.1146/annurev-chembioeng-062011-081052. Epub 2012 Mar 29. Annu Rev Chem Biomol Eng. 2012. PMID: 22468604 Review.

Cite

Share

5

Cite

Share

Toward aggregation-resistant antibodies by design.

Lee CC, Perchiacca JM, Tessier PM. Lee CC, et al. Among authors: tessier pm. Trends Biotechnol. 2013 Nov;31(11):612-20. doi: 10.1016/j.tibtech.2013.07.002. Epub 2013 Aug 7. Trends Biotechnol. 2013. PMID: 23932102 Review.

Cite

Share

6

Cite

Share

Engineered Autonomous Human Variable Domains.

Nilvebrant J, Tessier PM, Sidhu SS. Nilvebrant J, et al. Among authors: tessier pm. Curr Pharm Des. 2016;22(43):6527-6537. doi: 10.2174/1381612822666160921143011. Curr Pharm Des. 2016. PMID: 27655414 Free PMC article. Review.

Cite

Share

7

Cite

Share

Selecting and engineering monoclonal antibodies with drug-like specificity.

Starr CG, Tessier PM. Starr CG, et al. Among authors: tessier pm. Curr Opin Biotechnol. 2019 Dec;60:119-127. doi: 10.1016/j.copbio.2019.01.008. Epub 2019 Feb 26. Curr Opin Biotechnol. 2019. PMID: 30822699 Free PMC article. Review.

Cite

Share

8

Cite

Share

Systematic Engineering of Optimized Autonomous Heavy-Chain Variable Domains.

Nilvebrant J, Ereño-Orbea J, Gorelik M, Julian MC, Tessier PM, Julien JP, Sidhu SS. Nilvebrant J, et al. Among authors: tessier pm. J Mol Biol. 2021 Oct 15;433(21):167241. doi: 10.1016/j.jmb.2021.167241. Epub 2021 Sep 9. J Mol Biol. 2021. PMID: 34508727

Cite

Share

9

Cite

Share

Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS-CoV-2 Variants.

Zupancic JM, Schardt JS, Desai AA, Makowski EK, Smith MD, Pornnoppadol G, Garcia de Mattos Barbosa M, Cascalho M, Lanigan TM, Tessier PM. Zupancic JM, et al. Among authors: tessier pm. Adv Ther (Weinh). 2021 Aug;4(8):2100099. doi: 10.1002/adtp.202100099. Epub 2021 Aug 2. Adv Ther (Weinh). 2021. PMID: 34514086 Free PMC article.

Cite

Share

10

Cite

Share

Highly sensitive detection of antibody nonspecific interactions using flow cytometry.

Makowski EK, Wu L, Desai AA, Tessier PM. Makowski EK, et al. Among authors: tessier pm. MAbs. 2021 Jan-Dec;13(1):1951426. doi: 10.1080/19420862.2021.1951426. MAbs. 2021. PMID: 34313552 Free PMC article.

Cite

Share